publication venue for
- Molecular profiling and management of mantle cell lymphoma. 2019
- Prognostic significance of early molecular response in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. 2014
- Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. 2001
- Thrombocytopenia and liver disease: pathophysiology and periprocedural management.. 2022. 2022
- Zebras and hen's teeth: recognition and management of rare T and NK lymphomas.. 2015. 2015
- Novel agents for follicular lymphoma.. 2010. 2010
- Prognostic markers and stratification of chronic lymphocytic leukemia.. 2010. 2010
- The academic job offer: what to expect and how to negotiate. 2009
- Novel therapies and role of transplant in the treatment of peripheral T-cell lymphomas. 2008
- Transitioning from fellowship to a physician-scientist career track. 2008
- An introduction to foundation and industry-sponsored research: practical and ethical considerations. 2007
- Reduced-intensity conditioning regimens for hematologic malignancies: what have we learned over the last 10 years? 2005
- Targeting CD20 in follicular NHL: novel anti-CD20 therapies, antibody engineering, and the use of radioimmunoconjugates. 2005
- Chronic Myelogenous Leukemia: Disease Biology and Current and Future Therapeutic Strategies. 2000
- Optimal strategies for carrier screening and prenatal diagnosis of α- and β-thalassemia. 2021
- Is there a role for immunosuppression in antiphospholipid syndrome? 2019
- Case-based roundtable on treatment approach for young, fit, newly diagnosed multiple myeloma patients. 2018
- Novel immunotherapy approaches to follicular lymphoma. 2018
- Sequencing of therapies in relapsed follicular lymphoma. 2018
- Where to start? Upfront therapy for follicular lymphoma in 2018. 2018
- HITs and misses in 100 years of heparin. 2017
- Optimizing therapy for mantle cell lymphoma. 2017
- Management of primary central nervous system lymphoma in children. 2016
- Role of the intestinal mucosa in acute gastrointestinal GVHD. 2016
- Epigenetic targeting and personalized approaches for AML. 2014
- Goals for chronic myeloid leukemia TK inhibitor treatment: how little disease is too much? 2014
- Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence. 2013
- Focus on the epigenome in the myeloproliferative neoplasms. 2013
- Targeting the epigenome and other new strategies in diffuse large B-cell lymphoma: beyond R-CHOP. 2013
- Dos and don'ts in diagnosing antiphospholipid syndrome. 2012
- How do novel molecular genetic markers influence treatment decisions in acute myeloid leukemia? 2012
- Interpreting new molecular genetics in myelodysplastic syndromes. 2012
- Novel cellular therapies for leukemia: CAR-modified T cells targeted to the CD19 antigen. 2012
- Novel approaches to the treatment of acute myeloid leukemia. 2011
- Stem cell transplantation for multiple myeloma: current and future status. 2011
- Allogeneic stem cell transplantation in follicular lymphoma: recent progress and controversy. 2009
- New advances in the pathogenesis and therapy of essential thrombocythemia. 2008
- The antiphospholipid syndrome. 2007
- An update on therapy of primary central nervous system lymphoma. 2006
- Defining and managing imatinib resistance. 2006
- Role of JAK-STAT signaling in the pathogenesis of myeloproliferative disorders. 2006
- Congenital and acquired thrombocytopenia. 2004
- Immunotherapeutic approaches for hematologic malignancies. 2004
- Low-grade lymphoma. 2004
- Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome. 2003
- Thrombotic disorders: diagnosis and treatment. 2003
- Chronic myelogenous leukemia. 2001
- Immunotherapy of Non-Hodgkin's lymphomas. 2001
- Platelets: an update on diagnosis and management of thrombocytopenic disorders. 2001
- Thrombophilia: what's a practitioner to do? 2001